title: Outcomes following liver transplantation.
abstract: As the field of Liver Transplantation has matured, survival alone is no longer an acceptable single metric of success. This chapter explores the impact of the PELD system for donor organ allocation, surgical modification of donor organs, living donation, and long-term transplant-related complications on overall quality of life and outcome. Strategies to improve survival, overall outcome, and health-related quality of life in long-term recipients are outlined.
authors.affiliation: The Pediatric Liver Care Center, Department of Pediatric Surgery/Transplantation, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA. frederick.ryckman@cchmc.org
authors.forename: Frederick C
authors.initials: FC
authors.lastname: Ryckman
authors.forename: John C
authors.initials: JC
authors.lastname: Bucuvalas
authors.forename: Jaimie
authors.initials: J
authors.lastname: Nathan
authors.forename: Maria
authors.initials: M
authors.lastname: Alonso
authors.forename: Greg
authors.initials: G
authors.lastname: Tiao
authors.forename: William F
authors.initials: WF
authors.lastname: Balistreri
mesh_terms: D002648:Child; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D017093:Liver Failure / Q000401:mortality / Q000601:surgery*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000379:methods* / Q000401:mortality; D010043:Outcome and Process Assessment, Health Care; D011183:Postoperative Complications / Q000209:etiology* / Q000401:mortality; D011788:Quality of Life; D012307:Risk Factors; D015996:Survival Rate; D014019:Tissue Donors / Q000600:supply & distribution; D014022:Tissue Survival
chemical_list: D007166:Immunosuppressive Agents